POTENT HUMAN P40-TRKA AGONISTS DERIVED FROM AN ANTIRECEPTOR MONOCLONAL-ANTIBODY

Citation
L. Lesauteur et al., POTENT HUMAN P40-TRKA AGONISTS DERIVED FROM AN ANTIRECEPTOR MONOCLONAL-ANTIBODY, The Journal of neuroscience, 16(4), 1996, pp. 1308-1316
Citations number
45
Categorie Soggetti
Neurosciences,Neurosciences
Journal title
ISSN journal
02706474
Volume
16
Issue
4
Year of publication
1996
Pages
1308 - 1316
Database
ISI
SICI code
0270-6474(1996)16:4<1308:PHPADF>2.0.ZU;2-K
Abstract
Monoclonal antibody (mAb) 5C3 directed against human p140 TrkA is a st ructural and functional mimic of nerve growth factor (NGF) and an arti ficial receptor agonist. mAb 5C3 binds in the NGF-docking site and, li ke NGF, it promotes TrkA internalization, TrkA and phosphatidylinosito l-3 kinase tyrosine phosphorylation, and increased transformation of T rkA-expressing fibroblasts. More important, mAb 5C3 protects human Trk A-expressing cells from apoptotic death in serum-free media. Interesti ngly, agonistic activity is observed with monomeric F-ab 5C3 fragments . mAb 5C3 (K-d similar to 2 nM) was used to study features of ligand b inding by TrkA and the distribution of TrkA protein in normal human br ain.